Immortal News is an independent editorial project focused on one beat: the science of living longer and aging better. Every day, we track the most consequential peer-reviewed longevity research and translate it into plain English and French for readers who want clarity, not marketing copy.
No hype. No supplement ads. Just the science, the context, and a clear sense of what matters.
01
We follow the full landscape of serious longevity reporting: aging biology, senolytics, caloric restriction, mTOR signaling, NAD+ pathways, epigenetic clocks, telomere research, clinical trials in life extension, and the occasional breakthrough that looks credible enough to change the conversation.
02
Our core product is a daily digest published in English and French. We scan top-tier journals and preprint servers including Nature, Cell, The New England Journal of Medicine, The Lancet, bioRxiv, and related sources, then pull out the papers worth a reader's time.
03
Immortal News is independently edited. We are not affiliated with a pharmaceutical company, a supplement brand, or a biotech firm. That distance matters. It lets us stay skeptical, separate evidence from wishful thinking, and keep the editorial line clean.
04
Free readers get the hook and opening paragraph of each digest. Premium subscribers pay $7 per month for the full digest, an ad-free reading experience, and early access to deeper analysis when a study deserves more than a summary.